Vascular Graft Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Hemodialysis Access Graft, Endovascular Stent Graft, Peripheral Vascular Graft, Coronary Artery By-pass Graft),
Market Overview
The Global Vascular Graft Market was valued at USD 1.29 Billion in 2024 and is anticipated t%li%reach USD 1.97 Billion by 2030, growing at a CAGR of 7.31% during the forecast period. The market is witnessing strong growth, primarily due t%li%the increasing prevalence of vascular disorders such as peripheral artery disease (PAD), aneurysms, and coronary artery disease (CAD). These conditions, which involve the narrowing or blockage of blood vessels, can lead t%li%critical complications like stroke, myocardial infarction, and limb ischemia, thereby necessitating surgical interventions using vascular grafts. Additionally, the rising volume of procedures such as coronary artery bypass grafting (CABG) and endovascular aneurysm repair (EVAR) has further supported demand. Vascular grafts play a crucial role in these surgeries by replacing or bypassing damaged blood vessels. Technological progress and product innovation are als%li%advancing the market. For example, in May 2022, UC Davis received a USD 3 million grant from the California Institute for Regenerative Medicine t%li%develop a next-generation vascular graft for hemodialysis patients. Such developments reflect the ongoing commitment of stakeholders t%li%enhance the performance and longevity of grafts, which is expected t%li%significantly boost market growth in the coming years.
Key Market Drivers
Increasing Prevalence of Cardiovascular Diseases
The global vascular graft market is primarily driven by the escalating incidence of cardiovascular conditions such as coronary artery disease, peripheral arterial disease, and aortic aneurysms. These diseases represent a growing health concern worldwide, largely attributed t%li%sedentary lifestyles, unhealthy diets, and an aging population. As more individuals develop comorbidities like hypertension, diabetes, and obesity, the risk of cardiovascular events increases, fueling the need for surgical interventions involving vascular grafts. This surge in disease burden directly correlates with rising demand for procedures like CABG and EVAR, where vascular grafts are essential for restoring adequate blood flow. As a result, the demand for graft-based solutions is set t%li%grow steadily, supporting overall market expansion.
Key Market Challenges
Stringent Regulatory Hurdles
A significant challenge in the vascular graft market lies in the rigorous regulatory landscape governing medical devices. Organizations such as the U.S. FDA and EMA mandate thorough evaluations t%li%ensure the safety and efficacy of vascular grafts, including extensive clinical trials and quality testing. While such standards are crucial for safeguarding public health, they contribute t%li%extended development timelines and higher compliance costs. This can be particularly burdensome for smaller firms with limited resources, ultimately restricting the pace of innovation and delaying patient access t%li%new products. Additionally, the need t%li%navigate varying regulatory frameworks across different countries complicates global product approvals and increases market entry barriers for manufacturers.
Key Market Trends
Technological Advancements
Continuous innovation in graft materials and design is a key trend shaping the vascular graft market. Advanced materials, such as bioengineered and tissue-engineered grafts, have significantly enhanced the safety and performance of these products by improving biocompatibility and reducing the risk of complications. Furthermore, grafts featuring anti-thrombogenic and anti-infective coatings are gaining traction, offering better outcomes in terms of long-term patency and infection prevention. These developments not only improve surgical success rates but als%li%enable wider application of vascular grafts in complex procedures. As technologies evolve, next-generation grafts are expected t%li%play a more prominent role in vascular surgeries, encouraging wider clinical adoption and contributing t%li%market growth.
Key Market Players
In this report, the Global Vascular Graft Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Vascular Graft Market.
Available Customizations:
Global Vascular Graft Market report with the given market data, TechSci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
The Global Vascular Graft Market was valued at USD 1.29 Billion in 2024 and is anticipated t%li%reach USD 1.97 Billion by 2030, growing at a CAGR of 7.31% during the forecast period. The market is witnessing strong growth, primarily due t%li%the increasing prevalence of vascular disorders such as peripheral artery disease (PAD), aneurysms, and coronary artery disease (CAD). These conditions, which involve the narrowing or blockage of blood vessels, can lead t%li%critical complications like stroke, myocardial infarction, and limb ischemia, thereby necessitating surgical interventions using vascular grafts. Additionally, the rising volume of procedures such as coronary artery bypass grafting (CABG) and endovascular aneurysm repair (EVAR) has further supported demand. Vascular grafts play a crucial role in these surgeries by replacing or bypassing damaged blood vessels. Technological progress and product innovation are als%li%advancing the market. For example, in May 2022, UC Davis received a USD 3 million grant from the California Institute for Regenerative Medicine t%li%develop a next-generation vascular graft for hemodialysis patients. Such developments reflect the ongoing commitment of stakeholders t%li%enhance the performance and longevity of grafts, which is expected t%li%significantly boost market growth in the coming years.
Key Market Drivers
Increasing Prevalence of Cardiovascular Diseases
The global vascular graft market is primarily driven by the escalating incidence of cardiovascular conditions such as coronary artery disease, peripheral arterial disease, and aortic aneurysms. These diseases represent a growing health concern worldwide, largely attributed t%li%sedentary lifestyles, unhealthy diets, and an aging population. As more individuals develop comorbidities like hypertension, diabetes, and obesity, the risk of cardiovascular events increases, fueling the need for surgical interventions involving vascular grafts. This surge in disease burden directly correlates with rising demand for procedures like CABG and EVAR, where vascular grafts are essential for restoring adequate blood flow. As a result, the demand for graft-based solutions is set t%li%grow steadily, supporting overall market expansion.
Key Market Challenges
Stringent Regulatory Hurdles
A significant challenge in the vascular graft market lies in the rigorous regulatory landscape governing medical devices. Organizations such as the U.S. FDA and EMA mandate thorough evaluations t%li%ensure the safety and efficacy of vascular grafts, including extensive clinical trials and quality testing. While such standards are crucial for safeguarding public health, they contribute t%li%extended development timelines and higher compliance costs. This can be particularly burdensome for smaller firms with limited resources, ultimately restricting the pace of innovation and delaying patient access t%li%new products. Additionally, the need t%li%navigate varying regulatory frameworks across different countries complicates global product approvals and increases market entry barriers for manufacturers.
Key Market Trends
Technological Advancements
Continuous innovation in graft materials and design is a key trend shaping the vascular graft market. Advanced materials, such as bioengineered and tissue-engineered grafts, have significantly enhanced the safety and performance of these products by improving biocompatibility and reducing the risk of complications. Furthermore, grafts featuring anti-thrombogenic and anti-infective coatings are gaining traction, offering better outcomes in terms of long-term patency and infection prevention. These developments not only improve surgical success rates but als%li%enable wider application of vascular grafts in complex procedures. As technologies evolve, next-generation grafts are expected t%li%play a more prominent role in vascular surgeries, encouraging wider clinical adoption and contributing t%li%market growth.
Key Market Players
- Abbott Laboratories
- Braun Melsungen AG
- Becton, Dickinson and Company (Bard Peripheral Vascular Inc.)
- Cardinal Health (Cordis Corporation)
- Cook Medical
- Endologix Inc.
- Getinge Group
- LeMaitre Vascular Inc.
- Medtronic PLC
- Terum%li%Medical Corporation
In this report, the Global Vascular Graft Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
- Vascular Graft Market, By Product:
- Hemodialysis Access Graft Endovascular Stent Graft
- Peripheral Vascular Graft
- Coronary Artery By-pass Graft
- Vascular Graft Market, By Drug Application:
- Aneurysms
- Kidney Failure
- Vascular Occlusion
- Coronary Artery Diseases
- Other Applications
- Vascular Graft Market, By Region:
- North America
- United States
- Mexico
- Canada
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia-Pacific
- China
- India
- South Korea
- Japan
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Vascular Graft Market.
Available Customizations:
Global Vascular Graft Market report with the given market data, TechSci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up t%li%five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL VASCULAR GRAFT MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Hemodialysis Access Graft, Endovascular Stent Graft, Peripheral Vascular Graft, Coronary Artery By-pass Graft)
5.2.2. By Application (Aneurysms, Kidney Failure, Vascular Occlusion, Coronary Artery Diseases, Other Applications)
5.2.3. By Company (2024)
5.2.4. By Region
5.3. Market Map
6. NORTH AMERICA VASCULAR GRAFT MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Vascular Graft Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.2. Mexico Vascular Graft Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.3. Canada Vascular Graft Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
7. EUROPE VASCULAR GRAFT MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Vascular Graft Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.2. Germany Vascular Graft Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.3. United Kingdom Vascular Graft Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.4. Italy Vascular Graft Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.5. Spain Vascular Graft Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
8. ASIA-PACIFIC VASCULAR GRAFT MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Vascular Graft Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.2. India Vascular Graft Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.3. South Korea Vascular Graft Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.4. Japan Vascular Graft Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.5. Australia Vascular Graft Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
9. SOUTH AMERICA VASCULAR GRAFT MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Vascular Graft Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.2. Argentina Vascular Graft Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.3. Colombia Vascular Graft Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
10. MIDDLE EAST AND AFRICA VASCULAR GRAFT MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Vascular Graft Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.2. Saudi Arabia Vascular Graft Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.3. UAE Vascular Graft Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. PESTLE ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. COMPETITIVE LANDSCAPE
15.1. Abbott Laboratories
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Braun Melsungen AG
15.3. Becton, Dickinson and Company (Bard Peripheral Vascular Inc.)
15.4. Cardinal Health (Cordis Corporation)
15.5. Cook Medical
15.6. Endologix Inc.
15.7. Getinge Group
15.8. LeMaitre Vascular Inc.
15.9. Medtronic PLC
15.10. Terumo Medical Corporation.
16. STRATEGIC RECOMMENDATION
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL VASCULAR GRAFT MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Hemodialysis Access Graft, Endovascular Stent Graft, Peripheral Vascular Graft, Coronary Artery By-pass Graft)
5.2.2. By Application (Aneurysms, Kidney Failure, Vascular Occlusion, Coronary Artery Diseases, Other Applications)
5.2.3. By Company (2024)
5.2.4. By Region
5.3. Market Map
6. NORTH AMERICA VASCULAR GRAFT MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Vascular Graft Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.2. Mexico Vascular Graft Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.3. Canada Vascular Graft Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
7. EUROPE VASCULAR GRAFT MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Vascular Graft Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.2. Germany Vascular Graft Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.3. United Kingdom Vascular Graft Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.4. Italy Vascular Graft Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.5. Spain Vascular Graft Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
8. ASIA-PACIFIC VASCULAR GRAFT MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Vascular Graft Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.2. India Vascular Graft Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.3. South Korea Vascular Graft Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.4. Japan Vascular Graft Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.5. Australia Vascular Graft Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
9. SOUTH AMERICA VASCULAR GRAFT MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Vascular Graft Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.2. Argentina Vascular Graft Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.3. Colombia Vascular Graft Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
10. MIDDLE EAST AND AFRICA VASCULAR GRAFT MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Vascular Graft Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.2. Saudi Arabia Vascular Graft Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.3. UAE Vascular Graft Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. PESTLE ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. COMPETITIVE LANDSCAPE
15.1. Abbott Laboratories
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Braun Melsungen AG
15.3. Becton, Dickinson and Company (Bard Peripheral Vascular Inc.)
15.4. Cardinal Health (Cordis Corporation)
15.5. Cook Medical
15.6. Endologix Inc.
15.7. Getinge Group
15.8. LeMaitre Vascular Inc.
15.9. Medtronic PLC
15.10. Terumo Medical Corporation.
16. STRATEGIC RECOMMENDATION
17. ABOUT US & DISCLAIMER
